MK

Max Klement

Life Science Venture Capital

Greater London, England

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $1,000,000.00

  • Target Investment:

    $500,000.00

Skills

Cell Culture
Fluorescence Microscopy
Confocal Microscopy
Matlab
Microsoft Office
Molecular Biology
Microbiol
Fermentation Technology
Surface Plasmon Resonance
Mammalian Cell Culture
Image Processing
Protein Assays
Protein Purification
HPLC
Affinity Chromatography
Differential Scanning Calorimetry
Flow Cytometry
Technical Writing
AutoCAD
Gel Electrophoresis

Education

Lists including Max

AP
AO
AS
AN

Based in UK

1884 people

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Investments

Complement Therapeutics

Seed

Total Funding: $85M

Work Experience

NH
Novo Holdings

2022

  • Principal, Venture Investments

    2022

B(
BGV (BioGeneration Ventures)

2019 - 2022

  • Principal

    2022 - 2022

    Board director at Complement Therapeutics. Board observer at Dualyx, Link Immunotherapeutics, and VarmX.

  • Senior Associate

    2020 - 2021

  • Associate

    2019 - 2020

EB
Eden Biologics

2016 - 2017

  • Project Manager/ Upstream Process Development Scientist

    2016 - 2017

HB
Hummingbird Bioscience

2014 - 2016

  • Project Manager

    2014 - 2016

UN
United Nations ESCAP

2015 - 2015

  • Environment and Development Division

    2015 - 2015

A-
A*STAR - Agency for Science, Technology and Research

2010 - 2014

  • Research Fellow

    2010 - 2014